Guardant Health price target raised to $120 from $100 at BofA [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
The firm is updating it price targets for Life Sciences & Diagnostic Tools stocks under its coverage, the analyst tells investors. Headwinds are expected to fade, and markets are expected to normalize in 2026, firm adds. The firm believes the biggest upside for the sector will be a return to spending by Biopharma, leading BofA to favor companies with higher exposure to research and development. Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now See Insiders' Hot Stocks on TipRanks Read More on GH: Disclaimer & Disclosure Report an Issue Guardant Health price target raised to $155 from $115 at Leerink Guardant Health: Strong Growth Potential and Market Positioning Justify Buy Rating
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at JPMorgan Chase & Co. from $90.00 to $120.00. They now have an "overweight" rating on the stock.MarketBeat
- Guardant Health (NASDAQ:GH) was given a new $155.00 price target on by analysts at Leerink Partners.MarketBeat
- Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Guardant Health (GH): Reassessing Valuation After a Sharp Share Price Recovery [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 12/15/25 - Form 144
- 12/10/25 - Form 4
- 12/10/25 - Form 4
- GH's page on the SEC website